Payment overview · 2025
General Payments
$8.63
1 reported records · 1 companies
Healthcare provider profile · identity verified
Kelsie Gilley, APRN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · BEAUMONT, TX · NPI 1023623964
Verified facts
What the public records show
CMS Open Payments records show Kelsie Gilley, APRN received $8.63 in general payments during 2025 across 1 reported records.
Organon LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Organon LLC | Unresolved — no canonical attribution shown | $8.63 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $8.63 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NEXPLANON Normalized: nexplanon |
Drug | Organon LLC | $8.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 257 | 86 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 212 | 71 |
| Furosemide | Furosemide | 180 | 75 |
| Levothyroxine Sodium | Levothyroxine Sodium | 179 | 65 |
| Atorvastatin Calcium | Atorvastatin Calcium | 166 | 68 |
| Methylprednisolone | Methylprednisolone | 165 | 122 |
| Trazodone Hcl | Trazodone Hcl | 164 | 49 |
| Montelukast Sodium | Montelukast Sodium | 141 | 59 |
| Pantoprazole Sodium | Pantoprazole Sodium | 133 | 56 |
| Amlodipine Besylate | Amlodipine Besylate | 131 | 48 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 121 | 101 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 117 | 87 |
| Lisinopril | Lisinopril | 108 | 43 |
| Clonidine Hcl | Clonidine Hcl | 106 | 50 |
| Tramadol Hcl | Tramadol Hcl | 102 | 41 |
| Azithromycin | Azithromycin | 100 | 83 |
| Potassium Chloride | Potassium Chloride | 98 | 39 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 93 | 76 |
| Clonazepam | Clonazepam | 91 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 91 | 37 |
| Eliquis | Apixaban | 88 | 28 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 87 | 81 |
| Losartan Potassium | Losartan Potassium | 79 | 29 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 73 | 29 |
| Lorazepam | Lorazepam | 71 | 14 |
| Donepezil Hcl | Donepezil Hcl | 70 | 25 |
| Fluconazole | Fluconazole | 70 | 54 |
| Metformin Hcl | Metformin Hcl | 70 | 31 |
| Alprazolam | Alprazolam | 69 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 69 | 17 |
| Meloxicam | Meloxicam | 69 | 35 |
| Carvedilol | Carvedilol | 68 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 67 | 22 |
| Buspirone Hcl | Buspirone Hcl | 66 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 66 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 64 | 25 |
| Nystatin | Nystatin | 64 | 30 |
| Famotidine | Famotidine | 63 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 58 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 55 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 55 | 21 |
| Levofloxacin | Levofloxacin | 53 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 51 | 20 |
| Simvastatin | Simvastatin | 51 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 50 | 13 |
| Cephalexin | Cephalexin | 49 | 37 |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | 14 |
| Pregabalin | Pregabalin | 49 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 48 | 14 |
| Ondansetron Odt | Ondansetron | 45 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 45 | 19 |
| Divalproex Sodium | Divalproex Sodium | 43 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 43 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 39 | 19 |
| Midodrine Hcl | Midodrine Hcl | 39 | 13 |
| Allopurinol | Allopurinol | 38 | 21 |
| Lamotrigine | Lamotrigine | 38 | suppressed |
| Omeprazole | Omeprazole | 38 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 35 | 14 |
| Lactulose | Lactulose | 34 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 33 | 13 |
| Nitroglycerin | Nitroglycerin | 32 | 17 |
| Olanzapine | Olanzapine | 32 | suppressed |
| Baclofen | Baclofen | 30 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 30 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 30 | 14 |
| Xarelto | Rivaroxaban | 30 | suppressed |
| Bumetanide | Bumetanide | 29 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 26 |
| Amoxicillin | Amoxicillin | 28 | 26 |
| Aripiprazole | Aripiprazole | 28 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 28 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 16 |
| Warfarin Sodium | Warfarin Sodium | 27 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 26 | 14 |
| Promethazine Hcl | Promethazine Hcl | 26 | 16 |
| Cefdinir | Cefdinir | 25 | 20 |
| Divalproex Sodium Er | Divalproex Sodium | 25 | suppressed |
| Prednisone | Prednisone | 25 | 12 |
| Spironolactone | Spironolactone | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Ozempic | Semaglutide | 23 | 11 |
| Temazepam | Temazepam | 23 | suppressed |
| Torsemide | Torsemide | 22 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Linzess | Linaclotide | 20 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 18 | suppressed |
| Mirtazapine | Mirtazapine | 18 | suppressed |
| Bupropion Xl | Bupropion Hcl | 17 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 17 | suppressed |
| Constulose | Lactulose | 16 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 16 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 15 | 14 |
| Memantine Hcl | Memantine Hcl | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Nateglinide | Nateglinide | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | 12 |
| Risperidone | Risperidone | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Paliperidone Er | Paliperidone | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Flunisolide | Flunisolide | 11 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 11 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 11 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $8.63 · 1 records | Organon LLC | NEXPLANON | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error